Ghana vs Heavily indebted poor countries (HIPC): Antiretroviral therapy coverage for PMTCT
Ghana
99.0%
in 2024
Heavily indebted poor countries (HIPC)
84.7%
in 2024
Ghana rank
5th
Heavily indebted poor countries (HIPC) rank
7th
Antiretroviral therapy coverage for PMTCT over time
- Ghana
- Heavily indebted poor countries (HIPC)
How they compare
Ghana currently reports 99.0% against 84.7% in Heavily indebted poor countries (HIPC), a difference of 14.3%.
That makes Ghana's figure about 1.2 times Heavily indebted poor countries (HIPC)'s.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Heavily indebted poor countries (HIPC) ahead.
Ghana ranks 5th and Heavily indebted poor countries (HIPC) ranks 7th of 84 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Heavily indebted poor countries (HIPC) in 2.
Head to head by decade
| Decade | Ghana | Heavily indebted poor countries (HIPC) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 17.2% | 7.6% | Heavily indebted poor countries (HIPC) |
| 2010s | 59.9% | 71.9% | 12.0% | Heavily indebted poor countries (HIPC) |
| 2020s | 89.0% | 84.1% | 4.9% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ghana or Heavily indebted poor countries (HIPC)?
- Ghana, at 99.0% against 84.7% in Heavily indebted poor countries (HIPC) as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ghana and Heavily indebted poor countries (HIPC)?
- 14.3%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Heavily indebted poor countries (HIPC)?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and Heavily indebted poor countries (HIPC) rank globally for antiretroviral therapy coverage for pmtct?
- Ghana ranks 5th and Heavily indebted poor countries (HIPC) ranks 7th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).